Related Articles
Prognostic markers in clinically localised prostate cancer.
A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy
Identification of TCL1A as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas
Application of a new technique, spiral tissue microarrays constructed using needle biopsy specimens, to prostate cancer research
Cell-cycle-associated markers and clinical outcome in human epithelial cancers: A tissue microarray study